Stay updated on EXN407 Safety & Tolerability Clinical Trial
Sign up to get notified when there's something new on the EXN407 Safety & Tolerability Clinical Trial page.

Latest updates to the EXN407 Safety & Tolerability Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check48 days agoChange DetectedThe web page has been updated to include new results and detailed descriptions of the study involving EXN407, including specific objectives and methodologies for evaluating ocular safety and pharmacokinetics in subjects with Diabetic Macular Oedema (DMO). Notably, the results reporting dates have also been added.SummaryDifference22%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check76 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on Diabetic Macular Edema, while retaining the names of collaborators and the revision number.SummaryDifference27%
Stay in the know with updates to EXN407 Safety & Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EXN407 Safety & Tolerability Clinical Trial page.